Leerink analyst

Related by string. * : Leerink Swann . Leerink Swann analyst . Leerink Swann LLC . Leerink . Leerink Swan . Leerink Swan analyst . A. Leerink / analysts . ANALYSTS . ANALYST . Analysts . Analyst : WHAT 'S EXPECTED Analysts . Zacks Analyst Blog Highlights . Analysts polled . analysts polled . Interviews Analyst . Investors Observer Analysts Favorites . Analysts Begin Coverage . analyst Meredith Whitney * *

Related by context. All words. (Click for frequent words.) 61 DepoMed 61 Seattle Genetics SGEN 60 SSRX 60 Transcept Pharma 60 QCOR 59 OPTR 59 Nasdaq IPXL 59 ZIOP 59 NBIX 59 AUXL 58 BMTI 58 Exelixis EXEL 58 IDIX 58 analyst Liana Moussatos 58 Nasdaq CADX 58 NASDAQ REGN 58 NYMX 58 AMAG Pharma 58 ONXX 58 Myriad Genetics MYGN 58 NASDAQ ACOR 58 Celgene NASDAQ CELG 58 ALXA 58 Hologic HOLX 57 Apricus Biosciences 57 Tenthoff 57 Medivation MDVN 57 RDEA 57 CYTR 57 Speculative Buy recommendation 57 KERX 57 Impax Labs 57 NASDAQ SOMX 57 BMRN 57 Anadys Pharma 57 MannKind MNKD 57 CLDX 57 AMEX ANX 57 Santarus SNTS 57 THRX 56 IVGN 56 NASDAQ VRTX 56 Biogen NASDAQ BIIB 56 VPHM 56 DepoMed Inc. 56 SCLN 56 INHX 56 NASDAQ ADLR 56 Nps Pharmaceuticals Incorporated 56 Cell Therapeutics CTIC 56 MNTA 56 Affymax AFFY 56 OGXI 56 NASDAQ ANDS 56 Saftlas 56 IPXL 56 Auxilium Pharma 56 Arqule 56 PDL BioPharma PDLI 56 SGMO 56 Trimeris TRMS 56 EXAS 56 Onyx Pharmaceuticals ONXX 56 PharmaNet Development 56 SUPG 55 Regeneron Pharmaceuticals REGN 55 Endo Pharmaceuticals ENDP 55 Alkermes ALKS 55 Piper Jaffray downgraded 55 Jon Lecroy 55 Pain Therapeutics PTIE 55 MLNM 55 NASDAQ ONXX 55 REGN 55 KOSP 55 OPXA 55 Harry Palmin President 55 ISPH 55 ARQL 55 CYTX 55 Cyclacel Pharmaceuticals 55 Forest Labs FRX 55 ImmunoGen IMGN 55 Nymox Pharmaceutical 55 WuXi PharmaTech WX 55 BPAX 55 VICL 55 AMRN 55 NASDAQ ALIM 55 ARYX 55 TooNiceStocks 55 NASDAQ PARD 55 Allos Therapeutics Incorporated 55 Ziopharm 55 Isis Pharmaceuticals ISIS 55 CLDA 55 ENZN 55 DRRX 55 PerkinElmer PKI 54 MDVN 54 ZGEN 54 Isis Pharma 54 CRTX 54 DVAX 54 AMEX OPK 54 CRXX 54 Monane 54 Array Biopharma 54 Leerink Swan 54 VRTX 54 MOGN 54 CPRX 54 Allos Therapeutics ALTH 54 ALTH 54 Regeneron Pharma 54 Delcath Systems DCTH 54 Biodel BIOD 54 analyst Simos Simeonidis 54 Jefferies JEF 54 Depomed DEPO 54 Amylin Pharma 54 NASDAQ SLXP 54 QLTI 54 Gen Probe Nasdaq GPRO 54 Alnylam ALNY 54 Shire plc SHPGY 54 CRME 54 Alexion Pharmaceuticals Inc 54 Human Genome Sciences HGSI 54 LGND 54 Nasdaq AVNR 54 TSRX 54 INCY 54 Cypress Bioscience CYPB 54 Simeonidis 53 RXII 53 INSM 53 Pantginis 53 IDEV 53 Progenics Pharmaceuticals 53 Adventrx 53 PDL BioPharma Inc 53 Rigel Pharmaceuticals 53 Flamel Technologies 53 Cytokinetics CYTK 53 VNDA 53 Oscar Gruss 53 KV.A 53 Scolr Pharma 53 PDL Biopharma 53 Leerink 53 OSIP 53 NEUTRAL rating 53 IART 53 ARCA Biopharma 53 Eric Ende 53 NASDAQ VPHM 53 Biomarin 53 Xenoport Inc. 53 NOVN 53 Adventrx Pharmaceuticals 53 Finncap 53 Salix Pharmaceuticals SLXP 53 CELG 53 Allscripts Healthcare 53 BioMarin Pharma 53 WCRX 53 NASDAQ PCYC 53 NASDAQ ACAD 53 Pharmasset VRUS 53 analyst Bruce Cranna 53 SOMX 53 Momenta Pharmaceuticals MNTA 53 TLCR 53 SVNT 53 Novavax NASDAQ NVAX 53 PRXL 53 eResearchTechnology 53 Amylin AMLN 53 Fairly Valued stance 53 Mylan Labs MYL 53 ROSG 53 Diagnostic Substances industry 53 ABIO 53 Guides FY# Quick Facts 53 Cardica CRDC 53 Adeona Pharmaceuticals 53 Savient Pharma 53 PSDV 53 VRUS 53 ANIK 53 Pozen POZN 53 CADX 53 Salix Pharma 53 Speculative Buy 53 HITK 53 Inhibitex INHX 53 PLXS 53 Cubist Pharmaceuticals Inc 53 Vertex Pharmaceuticals VRTX 53 ALXN 53 ZymoGenetics ZGEN 53 analyst Mark Monane 52 Cephalon CEPH 52 Biovail BVF 52 Thermo Fisher TMO 52 NASDAQ INCY 52 Nasdaq ANDS 52 OUTPERFORM rating 52 AMEX PLX 52 Acorda Therapeutics Nasdaq ACOR 52 BNVI 52 Akhtar Samad 52 PRGO 52 SPNC 52 QLT QLTI 52 IMGN 52 ABII 52 analyst Randall Stanicky 52 Vanda Pharma 52 Mark Monane 52 Onyx Pharma 52 PNSN 52 SGEN 52 analyst Cory Kasimov 52 POZN 52 Affymax Inc. 52 Achillion Pharmaceuticals 52 Oxigene 52 XenoPort NASDAQ XNPT 52 Nasdaq OPTR 52 Nasdaq INCY 52 DORB 52 Nasdaq PARD 52 PiperJaffray analyst 52 Vertex Pharmaceuticals NASDAQ VRTX 52 BiolineRX 52 Abbott ABT 52 Array BioPharma ARRY 52 Nasdaq SLXP 52 Curagen 52 Mkt Outperform 52 ImmunoCellular Therapeutics 52 AFFY 52 Novadel 52 Enzon Pharmaceuticals ENZN 52 Star Scientific STSI 52 Cardionet 52 Tibco TIBX 52 Inc. NASDAQ ITMN 52 United Therapeutics UTHR 52 Novellus Nasdaq NVLS 52 Cephalon NASDAQ CEPH 52 Optimer Pharmaceuticals 52 Momenta Pharma 52 Oncothyreon Inc 52 NASDAQ AEZS 52 AMEX RNN 52 Nasdaq IDIX 52 Bristol Myers BMY 52 Maintains Hold 52 Annabel Samimy 52 Sector Outperform 52 Therapeutic Competitors companiesandmarkets.com adEgemonye 52 NASDAQ IPXL today 52 Ardea Biosciences 52 TapImmune 52 AVNR 52 Ariad Pharmaceuticals 52 Matria Healthcare Inc 52 AMAG Pharmaceuticals Inc. 52 CardioVascular BioTherapeutics 52 GNLB 52 Atherogenics 52 Insmed Incorporated NASDAQ INSM 52 GNVC 52 Avanir Pharma 52 NASDAQ SVNT 52 Navdeep Jaikaria 52 Idenix Pharma 52 Therapeutic Competitors 52 Psivida 52 ENCY 52 MBRX 52 DELEX 52 PDGI 51 STXS 51 Prolor Biotech 51 Khandaker Partners 51 #QF# 51 Nollenberger Capital 51 Chindex CHDX 51 Sequenom SQNM 51 Protalix BioTherapeutics 51 Sepracor SEPR 51 NPS Pharmaceuticals NPSP 51 BioMedTracker 51 Eurand NV NASDAQ EURX 51 SHPGY 51 CBST 51 MNKD 51 analyst Amit Hazan 51 Nasdaq ACAD 51 Endo Pharmaceuticals NASDAQ ENDP 51 NASDAQ IPXL 51 Cantor Fitzgerald reiterates 51 Intermune ITMN 51 VIVUS VVUS 51 FQ2 51 ALNY 51 GTOP 51 NuVasive NUVA 51 Andrx ADRX 51 Durect Corp. 51 Integra Lifesciences 51 Acorda Therapeutics ACOR 51 NASDAQ QCOR 51 Brean Murray downgrades 51 reaffirmed Outperform rating 51 OTCBB NEOP 51 Oncogenex 51 Acorda Therapeutics NASDAQ ACOR 51 Avanir Pharmaceuticals 51 Myriad Genetics Inc 51 INFA 51 NASDAQ AVEO 51 CE Unterberg 51 BioMed Realty 51 Savient Pharmaceuticals SVNT 51 analyst Amit Bhalla 51 BPSG 51 analyst Hari Sambasivam 51 Dr. Menawat 51 Eurand NV EURX 51 CYBX 51 Cephalon Nasdaq CEPH 51 DYAX 51 Pharmion PHRM 51 TNGN 51 PDLI 51 ELRN 51 Lifecycle Pharma 51 Vertex Pharma 51 OSUR 51 Aegerion Pharmaceuticals 51 Theravance THRX 51 Regeneron REGN 51 William Plovanic 51 IMMU 51 NASDAQ CYPB 51 SXCI 51 Myriad Genetics Nasdaq MYGN 51 MRGE 51 ELGX 51 Angiotech Pharma 51 NASDAQ PRXL 51 Perrigo PRGO 51 SLXP 51 ATHX 51 Neurosearch 51 LCRY 51 Impax Laboratories IPXL 51 Axcan Pharma 51 Inc. NASDAQ MRNA 51 Gilead GILD 51 CNMD 51 Penwest Pharmaceuticals 51 Momenta Pharmaceuticals Inc 51 Align Technology ALGN 51 Immunogen 51 UFPT 51 AMLN 51 Netresearch 51 GNBT 51 Helvea analyst Olav Zilian 51 SPPI 51 Sunesis Pharmaceuticals Inc. 51 SHP.L 51 Cepheid CPHD 51 Immunomedics Inc. 51 RenaMed 51 NPS Pharma 51 MYGN 51 Nabi Biopharmaceuticals NABI 51 Aryx Therapeutics 51 Valeant Pharmaceuticals VRX 51 CGNX 51 Dr. Damaj 51 ONTY 51 ViroPharma VPHM 50 Dynavax Technologies 50 HOLX 50 Celgene CELG 50 AstraZeneca AZN.ISE 50 NEOP 50 Jason Kolbert 50 AMAG Pharmaceuticals 50 NASDAQ ALXN 50 DOWNSIDE MOVERS 50 CV Therapeutics CVTX 50 Shire Pharmaceuticals SHPGY 50 Questcor Pharmaceuticals 50 BioMarin Pharmaceutical 50 Qlik Technologies Inc 50 Covanta CVA 50 NASDAQ ISIS 50 Piper Jaffray PJC 50 EYET 50 NUVA 50 GENZ 50 GORX 50 Nasdaq ZIOP 50 Amex ANX 50 Incyte INCY 50 Edwards Lifesciences EW 50 Bristol Myers NYSE BMY 50 Neostem 50 BRKS 50 Inc. Nasdaq AVII 50 NGSX 50 NLTX 50 Denhoy 50 EVVV 50 F1Q 50 Inc. NASDAQ ACOR 50 Sunesis Pharmaceuticals 50 Sanganeria 50 analyst Jim Reddoch 50 Valeant Pharmaceuticals NYSE VRX 50 DCTH 50 Keryx Biopharma 50 KNSY 50 Angiotech Pharmaceuticals ANPI 50 Dolat Capital Market 50 Investology 50 NASDAQ PGNX 50 GPRO 50 HYTM 50 AKRX 50 McKesson MCK 50 BioMarin Pharmaceutical BMRN 50 Omniture OMTR 50 Lazard Capital 50 Medivation Inc 50 Cytori Therapeutics CYTX 50 Nektar Therapeutics NKTR 50 Alkermes NASDAQ ALKS 50 Targacept TRGT 50 MBRK 50 Natixis Bleichroeder analyst 50 NASDAQ ALXA 50 Forest Laboratories FRX 50 Fairly Valued rating 50 QGEN 50 NASDAQ AMAG 50 Corp. ADLR 50 TRBN 50 FY#Q# 50 FLML 50 Acadia Pharmaceuticals 50 Brean Murray upgrades 50 Auxilium Pharmaceuticals 50 Orexigen Therapeutics OREX 50 Maintains Buy 50 Alexza Pharmaceuticals ALXA 50 Beckman Coulter BEC 50 Lipoxen 50 Alexion Pharmaceuticals ALXN 50 Integra LifeSciences IART 50 Bayer BAYRY 50 CardioGenics Holdings Inc. 50 Idenix Pharmaceuticals 50 Moussatos 50 PHRM 50 Nasdaq MOGN 50 CELGENE 50 Nasdaq QCOR 50 Stanicky 50 Polymeropoulos 50 NASDAQ BPAX 50 Biomed Realty Trust 50 volatility Elevated 50 OXPS 50 Way2Wealth Securities 50 DSCO 50 Teva Pharm 50 Penwest Pharma 50 Gilead Sciences NASDAQ GILD 50 NASDAQ VRUS 50 NEXM 50 Idenix Pharmaceuticals IDIX 50 SEPR 50 Regeneron Pharmaceuticals 50 Coverage Initiated 50 LJPC 50 TSPT 50 Isaac Ro 50 Tianyin Pharmaceutical 50 Outperformer 50 NASDAQ AKRX 50 Poniard Pharmaceuticals 50 CAVM 50 Speculative Buy rating 50 Diversified Industrials 50 Viropharma 50 Declares Dividend Quick Facts 50 ADRX 50 Amgen AMGN 50 AEterna 50 HSFT 50 Impax Laboratories Inc 50 Regeneron Pharmaceuticals Inc. 50 PANL 50 Guides FY# Update 50 Reiterates Buy 50 Inspire Pharmaceuticals Inc 50 BIOD 50 BCRX 50 AMAG 50 analyst Yaron Werber 50 SciClone Pharmaceuticals 50 Biosante 50 Bersoff 50 ImmunoVaccine Technologies 50 Undervalued stance 49 CAMPATH 49 Xenoport 49 Metabasis Therapeutics 49 Medarex MEDX 49 YM Biosciences 49 UGNE 49 Mr. Kriegsman 49 AVGO 49 Neibor 49 SNTS 49 Lexicon Pharmaceuticals 49 analyst Sapna Srivastava 49 Shire SHPGY 49 Flotek Industries 49 Edward Tenthoff 49 analyst Seamus Fernandez 49 Qiagen QGEN 49 ZRAN 49 NxStage Medical NXTM 49 NVMI 49 EURX 49 CYPB 49 RPRX 49 GLUU 49 Becton Dickinson BDX 49 Novavax NVAX 49 Allergan AGN 49 Kindred Healthcare KND 49 Encysive Pharmaceuticals Nasdaq ENCY 49 Concur Technologies Inc 49 EPCT 49 VTAL 49 Wells Fargo Initiates Coverage 49 NASDAQ CLDX 49 Helicos BioSciences Corporation 49 Noven Pharmaceuticals Inc 49 NASDAQ BDSI 49 Garth Likes 49 Joshua Schimmer 49 NASDAQ MATR announced 49 CR Bard BCR 49 NTMD 49 PFWD 49 ECTE 49 Valeant Pharma 49 LMNX 49 Fairly Valued 49 Overweight Rating 49 analyst Lawrence Keusch 49 PPCO 49 NASDAQ NPSP 49 NEOG 49 iStar Financial SFI 49 OIIM 49 Joel Sendek 49 AgFeed Industries FEED 49 NASDAQ MYGN 49 Arena Pharmaceuticals ARNA 49 Andrew Vaino 49 SGXP 49 QLIK 49 AvalonBay Communities AVB 49 VCLK 49 SPECULATIVE BUY 49 Sagent Pharmaceuticals Inc. 49 Vion Pharmaceuticals 49 Xtent 49 NetEase.com NASDAQ NTES 49 Alantos 49 Cypress Bioscience 49 OSI Pharma 49 Nasdaq ACOR 49 Nasdaq APPY 49 NSPH 49 Avanir Pharmaceuticals AVNR 49 Millennium Pharmaceuticals MLNM 49 OSI Pharmaceuticals OSIP 49 Alexza Pharmaceuticals Inc 49 JMP Securities downgrade 49 Schering SHR 49 #.#x #E [002] 49 Plovanic 49 ThinkEquity downgraded 49 Idera Pharmaceuticals 49 LIOX 49 HealthSpring HS 49 Maxim MXIM 49 Cell Genesys CEGE 49 ABGX 49 '#E EPS 49 Ardour Capital 49 Nasdaq ALXA 49 Inspire Pharma 49 Aaron Reames 49 Philip S. Pesin 49 Dendreon DNDN 49 Threshold Pharmaceuticals Inc. 49 Cepheid NASDAQ CPHD 49 Panagiotis Spiliopoulos 49 Piper Jaffray downgrades 49 Nymox Pharmaceutical Corporation 49 X Ceptor 49 ZGNX 49 Icagen ICGN 49 NASDAQ DCTH 49 Mindray Medical 49 DNEX 49 APPX 49 DrugResearcher.com 49 OUTPERFORM 49 Joseph Pantginis 49 F2Q 49 PCRX 49 BRE Properties BRE 49 Innovations IMA 49 Market Harmonics 49 Keay Nakae 49 Biomarin Pharm 49 XNPT 49 Gilead Sciences GILD 49 analyst Patrick Walravens 49 Pluristem Therapeutics 49 Onyx Pharmaceuticals 49 Fanandakis 49 NHWK 49 REIT Diversified 49 Alnylam Pharma 49 Nasdaq SVNT 49 Acadia Pharmaceuticals ACAD 49 NASDAQ ARIA 49 CVTX 49 Trubion Pharma 49 Alnylam Nasdaq ALNY 49 XTL Biopharmaceuticals 49 Nxstage Medical 49 Gilead Sciences nasdaq GILD 49 Cubist Pharma 49 MYRX 49 analyst Jason Napodano 49 Waters WAT 49 Jay Deahna 49 ADZA 49 Kalpesh Kapadia 49 ASX PGL 49 Trevor Polischuk 49 Nasdaq EPCT 48 HwangDBS Vickers 48 analyst Shebly Seyrafi 48 analyst Maged Shenouda 48 Amsurg 48 Maybank IB 48 CEPH 48 NASDAQ ALTH 48 Biogen Idec BIIB 48 RNOW 48 Ameristar Casinos ASCA 48 Sciele Pharma Inc. 48 Biomet BMET 48 SQNM 48 ESRX 48 analyst Jonathan Aschoff 48 HNAB 48 Cory Kasimov 48 Bonte Friedheim 48 Sam Fazeli 48 Rexahn Pharmaceuticals 48 NASDAQ PRCS 48 Inc Therapeutic Competitors 48 Steven Harr 48 KNXA 48 Biogen Nasdaq BIIB 48 Prolor 48 analyst Glenn Novarro 48 DUSA Pharmaceuticals 48 antibacterial therapeutics 48 Aegerion Pharmaceuticals Inc. 48 Canaccord Genuity reiterates 48 Biophan Technologies 48 NASDAQ WCRX 48 JMP Securities downgraded 48 Paramitra Alfa Sekuritas 48 Roger Longman 48 KV Pharma 48 Liana Moussatos 48 SangStat 48 Cannacord Genuity 48 Thermo Fisher Scientific TMO 48 Jason Kantor 48 Maintains Buy rating 48 Synta Pharmaceuticals 48 Maintains Outperform 48 Kochnover 48 Ananda Baruah 48 BioMarin BMRN 48 Rating Maintained 48 ENSCO PLC 48 F3Q 48 Allergan NYSE AGN 48 Company Report companiesandmarkets.com 48 NNAN 48 Joe Pantginis 48 VVUS 48 Ulrich Dauer CEO 48 BioSante Pharmaceuticals 48 Novelos Therapeutics 48 Peer Perform rating 48 Taleo TLEO 48 Juergen Engel Ph.D. 48 Inc. Nasdaq AFFY 48 Avanir 48 TKTX 48 Athenahealth ATHN 48 Cabrellis 48 Barry Labinger 48 CTRX 48 Biostar Pharmaceuticals 48 AstraZeneca AZN 48 Cerner CERN 48 Prosperity Bancshares PRSP 48 SYBT 48 Cleveland Biolabs 48 Tyco Electronics TEL 48 Fulcrum Global 48 BRICS PCG 48 Ronan O'Caoimh CEO 48 PRLS 48 Medical STJ 48 FBR Capital NASDAQ FBCM 48 FY# EPS estimate 48 Reiterate Buy 48 Feltl & 48 PRKR 48 analyst Hamed Khorsand 48 Amir Rozwadowski 48 Alexion Pharma 48 Divyesh Shah 48 Anika Therapeutics 48 Wayne Gattinella President 48 MEDX 48 VTUS 48 Corcept Therapeutics 48 NASDAQ OGXI 48 INWK 48 NASDAQ OSIP 48 AMGN 48 ADLR 48 CPNO 48 BUY Rating 48 Jerry Doctrow 48 Jeffrey Frelick 48 Neutral Analyst Blog 48 Idenix Pharmaceuticals Inc. 48 Teva Pharmaceutical TEVA 48 Sector Outperformer 48 RBC Capital NYSE RY 48 NASDAQ BCRX 48 ON Semiconductor ONNN 48 THLD 48 TPTH 48 Celera CRA 48 Maintains Neutral 48 Gentium SpA GENT 48 Amylin Eli Lilly 48 MELA Sciences 48 FQ1 48 McMoRan Exploration MMR 48 Becton Dickson 48 Spectrum Pharmaceuticals NASDAQ SPPI 48 JoAnne Feeney 48 CRXL 48 Nasdaq AMAG 48 David Amsellem 48 Dril Quip DRQ 48 Amgen NASDAQ AMGN 48 AEGR 48 MWIV 48 OSIR 48 Regeneron Pharms 48 Amag 48 Potelligent Technology 48 KOSN 48 Extreme Networks EXTR 48 Emkay Global 48 Eran Broshy 48 Spectrum Pharmaceuticals SPPI 48 Ultratech UTEK 48 Reiterates Hold 48 Greg Geissman 48 Synta Pharma 48 Electro Optical Sciences 48 Headwaters HW 48 Somaxon Pharmaceuticals 48 Capstone Investments 48 UCTT 48 Sector Performer rating 48 Zoltek Companies 48 Inc. NASDAQ FUQI 48 CRNT 48 Proactiveinvestors 48 Lawrence Keusch 48 Timothy Thein 48 OmniVision Technologies OVTI 48 NYSE COV 47 Staphos 47 EHTH 47 Sourcefire FIRE 47 Philippe Archinard 47 HTWR 47 Osiris Therapeutics 47 Napo Pharmaceuticals 47 Finisar NASDAQ FNSR 47 Matthew Kather 47 Catalyst Biosciences 47 Alimera Sciences Inc 47 Teva Pharmaceuticals TEVA 47 Elan ELN 47 INFI 47 Praecis 47 Biogen BIIB 47 Thoratec THOR 47 Reiterates Hold Rating 47 Nasdaq PHRM 47 Halozyme Therapeutics 47 Threshold Pharma 47 NASDAQ ARRY 47 FMC Technologies FTI 47 Anadys Pharmaceuticals 47 Yaron Werber 47 Allegra D# 47 NPS Pharmaceuticals NASDAQ NPSP 47 Ventrus 47 Keybanc 47 Cantel Medical Corp 47 Endo Pharmaceuticals Nasdaq ENDP 47 Jim Birchenough 47 RBC Capital Mkts 47 Warner Chilcott plc 47 Vertex Pharmaceuticals Nasdaq VRTX 47 DNAG 47 PVTB 47 Immucor BLUD 47 CNXT 47 Apollo APOL 47 Rigel Pharmaceuticals RIGL 47 Akorn Inc 47 Nuvion 47 ZLCS 47 Opko Health 47 KNDL 47 Barry D. Quart 47 Alphatec Holdings 47 Nasdaq CELG 47 AXTI 47 ALGN 47 PDL BioPharma 47 GXDX 47 Molowa 47 Teva Pharmaceutical NASDAQ TEVA 47 NTII 47 Durect 47 Piper Jaffray reiterates 47 Durect Corporation 47 Immunomedics 47 BioMarin Pharmaceuticals 47 Horst Hueniken 47 FQ3 47 Nasdaq AMLN 47 Alexza Pharmaceuticals Inc. 47 MXIM 47 TLVT 47 HWAY 47 Reiterates Outperform 47 Spreadtrum Communications SPRD 47 MTOX 47 Beverages Soft Drinks 47 MicroStrategy MSTR 47 Bank Degroof analyst 47 NASDAQ OMPI 47 NASDAQ MANT 47 Covidien plc NYSE COV 47 FTN Equity 47 Canaccord Genuity Reiterates Buy 47 QLGC 47 Eaton ETN 47 EnzymeRx 47 HURC 47 HGSI 47 Resumes Coverage 47 NASDAQ RDEA 47 James Manuso 47 Sinobiopharma 47 Zenpep 47 Covance CVD 47 Underweight rating 47 Amphenol APH 47 Caraco Pharma 47 Nasdaq DYAX 47 JMP Securities reiterates 47 Encysive Pharma 47 Encysive Pharmaceuticals 47 Ardea Biosciences Inc. 47 Curon Medical 47 Nanometrics NANO 47 Speculative Buy Rating 47 ESPR 47 BUY recommendation 47 GENR 47 MedImmune MEDI 47 NASDAQ CIEN 47 GNTA 47 Peregrine Pharmaceuticals 47 Aloprim 47 ISIS Pharmaceuticals 47 Sterne Agree 47 Achillion Pharmaceuticals Inc 47 Incyte Corporation 47 MDCO 47 Steven Kriegsman 47 WR Hambrecht analyst 47 Emisphere Technologies 47 Claude Camire 47 Aegerion 47 Allos Therapeutics 47 Beats Raises Guidance 47 Chief Executive Matthew Emmens 47 Maintains Buy Rating 47 Mike Tarsala 47 CIGNA CI 47 RBC Capital Mkts Reiterate 47 ULTI 47 Open Text OTEX 47 Nasdaq RDEA 47 Leerink Swan analyst 47 Neutral Weight 47 Cantel Medical 47 NASDAQ SHPGY 47 Stryker NYSE SYK 47 Hologic NASDAQ HOLX 47 Nicholas Landekic President 47 FoxHollow Technologies 47 Jim Reddoch 47 UPGRADED ONE WEEK AGO 47 Biogen Idec NASDAQ BIIB 47 Bank Vontobel analyst 47 Underperform recommendation 47 Q2 Adj 47 Indevus Pharmaceuticals IDEV 47 Rule Breakers pick 47 Century Aluminum CENX 47 Biosante Pharmaceuticals 47 Vivus VVUS 47 NASDAQ XRAY 47 NASDAQ TEVA 47 DiObex 47 Genelabs Technologies 47 ThinkPanmure 47 SCRX 47 CRZO 47 Applied NeuroSolutions 47 AEterna Zentaris Inc. 47 Per Olof Wallström 47 Poniard 47 Q4 Profit Decreases 47 Praecis Pharmaceuticals 47 John F. Thero 47 CBTE 47 Epicor Software EPIC 47 NYSE CFN 47 Eaton Vance EV 47 LKP Shares 47 ARNA 47 Sirona Dental 47 analyst Geoffrey Porges 47 analyst Kemp Dolliver

Back to home page